166 related articles for article (PubMed ID: 38501199)
21. Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Miyagahara T; Fujimori N; Ueda K; Takamatsu Y; Matsumoto K; Teramatsu K; Takaoka T; Suehiro Y; Shimokawa Y; Omori K; Niina Y; Tachibana Y; Akashi T; Oono T; Ogawa Y
Asia Pac J Clin Oncol; 2023 Aug; 19(4):533-541. PubMed ID: 36478079
[TBL] [Abstract][Full Text] [Related]
22. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
23. Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.
Yoneda KY; Scranton JR; Cadogan MA; Tassell V; Nadanaciva S; Wilner KD; Stollenwerk NS
Clin Lung Cancer; 2017 Sep; 18(5):472-479. PubMed ID: 28373069
[TBL] [Abstract][Full Text] [Related]
24. Management issues in rheumatoid arthritis-associated interstitial lung disease.
England BR; Hershberger D
Curr Opin Rheumatol; 2020 May; 32(3):255-263. PubMed ID: 32141954
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
26. [Molecular Mechanism-based Prediction of Interstitial Lung Disease Development Causedby Molecular Targeted Drugs: Association between Signal Transducer and Activator of Transcription 3 and Mammalian Target of Rapamycin inhibitor-induced Interstitial Lung Disease].
Yamamoto K
Yakugaku Zasshi; 2023; 143(11):911-916. PubMed ID: 37914338
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced infiltrative lung disease.
Camus PH; Foucher P; Bonniaud PH; Ask K
Eur Respir J Suppl; 2001 Sep; 32():93s-100s. PubMed ID: 11816828
[TBL] [Abstract][Full Text] [Related]
28. Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer.
Makris D; Scherpereel A; Copin MC; Colin G; Brun L; Lafitte JJ; Marquette CH
BMC Cancer; 2007 Aug; 7():150. PubMed ID: 17683587
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
[TBL] [Abstract][Full Text] [Related]
30. Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.
Yong WP; Teo FS; Teo LL; Ng MC; Tan TJ; Low SY; Wong K; Ang P; Choo SP; Lee KH; Lee SC
Expert Opin Drug Metab Toxicol; 2022 Dec; 18(12):805-815. PubMed ID: 36636012
[TBL] [Abstract][Full Text] [Related]
31. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study.
Suzuki Y; Karayama M; Uto T; Fujii M; Matsui T; Asada K; Kusagaya H; Kato M; Matsuda H; Matsuura S; Toyoshima M; Mori K; Ito Y; Koyauchi T; Yasui H; Hozumi H; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
J Thorac Oncol; 2020 Aug; 15(8):1317-1327. PubMed ID: 32289515
[TBL] [Abstract][Full Text] [Related]
33. Management of progressive pulmonary fibrosis associated with connective tissue disease.
Molina-Molina M; Castellví I; Valenzuela C; Ramirez J; Rodríguez Portal JA; Franquet T; Narváez J
Expert Rev Respir Med; 2022 Jul; 16(7):765-774. PubMed ID: 35912842
[TBL] [Abstract][Full Text] [Related]
34. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
[No Abstract] [Full Text] [Related]
35. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.
Atzeni F; Gerardi MC; Barilaro G; Masala IF; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2018 Jan; 14(1):69-82. PubMed ID: 29202589
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced interstitial pneumonia.
Prescrire Int; 2008 Apr; 17(94):61-3. PubMed ID: 18516814
[TBL] [Abstract][Full Text] [Related]
37. Advances with pharmacotherapy for the treatment of interstitial lung disease.
Comes A; Sgalla G; Perrotta A; Richeldi L
Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
[TBL] [Abstract][Full Text] [Related]
38. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
Powell CA; Modi S; Iwata H; Takahashi S; Smit EF; Siena S; Chang DY; Macpherson E; Qin A; Singh J; Taitt C; Shire N; Camidge DR
ESMO Open; 2022 Aug; 7(4):100554. PubMed ID: 35963179
[TBL] [Abstract][Full Text] [Related]
39. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
King CS; Shlobin OA
Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
[TBL] [Abstract][Full Text] [Related]
40. Management of Lung Cancer in the Patient with Interstitial Lung Disease.
Frank AJ; Dagogo-Jack I; Dobre IA; Tait S; Schumacher L; Fintelmann FJ; Fingerman LM; Keane FK; Montesi SB
Oncologist; 2023 Jan; 28(1):12-22. PubMed ID: 36426803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
